Aktis Oncology Inc
AKTSHealthcare|Biotechnology|USA
$27.88
-0.54 (-1.90%)
Tangible Book
$9.16
Clinical Trials (2)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07020117 A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors | Urothelial Carcinoma Bladder, Triple Negative Breast Cancer (TNBC) | P1 | Recruiting | 150 | Open-label | [225Ac]Ac-AKY-1189 (therapeutic), [64Cu]Cu-AKY-1189 (imaging) |
| NCT07581184 A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer | Castration Resistant Metastatic Prostate Cancer, Prostate Cancer | P1 | Recruiting | 138 | Open-label | [225Ac]Ac-AKY-2519 (therapeutic), [64Cu]Cu-AKY-2519 (imaging) |